| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.073 | 0.2 |